Breast cancer susceptibility associated with rs1219648 (fibroblast growth factor receptor 2) and postmenopausal hormone therapy use in a population-based United States study

Shaneda Warren Andersen, Amy Trentham-Dietz, Jonine D Figueroa, Linda J Titus, Qiuyin Cai, Jirong Long, John M Hampton, Kathleen M Egan, Polly A Newcomb

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Breast cancer susceptibility associated with rs1219648 (fibroblast growth factor receptor 2) and postmenopausal hormone therapy use in a population-based United States study'. Together they form a unique fingerprint.

Medicine & Life Sciences